Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St rises as chip rally offsets renewed Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices slide over 1% as US-Iran conflict clouds Hormuz reopening
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
July 30, 2020 4:01 PM EDTSecond Quarter and First Half 2020
- Second Quarter Product Sales of $5.1 billion -
- First Half Product Sales of $10.5 billion -
- Second Quarter GAAP Loss of $(2.66) per share -
- Second Quarter Non-GAAP Diluted EPS of $1.11 per share -
Revised Full Year 2020 Guidance
- Product Sales of $23 billion to $25 billion -
- Non-GAAP Diluted EPS... More
